(Q39038019)

8 September 2017

title

MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B. (English)

1 reference

8 September 2017

1 reference

hepatocellular carcinoma

1 reference

Qingliang Zheng

1

1 reference

8 September 2017

Qing Sheng

2

1 reference

8 September 2017

Caiying Jiang

3

1 reference

8 September 2017

Jianhong Shu

4

1 reference

8 September 2017

Jian Chen

5

1 reference

8 September 2017

Zuoming Nie

6

1 reference

8 September 2017

Zhengbing Lv

7

1 reference

8 September 2017

Yaozhou Zhang

8

1 reference

8 September 2017

publication date

1 January 2014

1 reference

Molecular and Cellular Biochemistry

8 September 2017

published in

1 reference

8 September 2017

volume

389

1 reference

8 September 2017

issue

1-2

1 reference

8 September 2017

page(s)

187-195

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1940-z

8 September 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Cellular and molecular mechanisms of hepatocellular carcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

The impact of microRNAs on protein output

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

MicroRNA function in cancer: oncogene or a tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Pocket proteins and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Conserved functions of the pRB and E2F families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Cdk inhibitors in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

CDK inhibitors in clinical development for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1940-Z

Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival.

1 reference

12 December 2020

Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma

1 reference

12 December 2020

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

1 reference

12 December 2020

Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Deregulation of the cell cycle in cancer

1 reference

12 December 2020

MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

1 reference

12 December 2020

10.1007/S11010-013-1940-Z

Identifiers

DOI

1 reference

8 September 2017

1 reference